1-20 of 290
Gilles Salles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume

Clinical Trials & Observations
Frederick L. Locke, Olalekan O. Oluwole, John Kuruvilla, Catherine Thieblemont, Franck Morschhauser, Gilles Salles, Steven P. Rowe, Saran Vardhanabhuti, Joshua Winters, Simone Filosto, Christina To, Paul Cheng, Marco Schupp, Ronald Korn, Marie José Kersten
Journal: Blood
Blood (2024) 143 (24): 2464–2473.
https://doi.org/10.1182/blood.2023021620
Published: 2024
Includes: Supplemental data
Journal Articles

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Clinical Trials & Observations
David A. Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham T. Wehmeyer, Jason Romancik, Behzad Amoozgar, Lori Leslie, Loretta J. Nastoupil, Jennifer L. Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami Maddocks, Sarah C. Rutherford, Brad Kahl, Michelle Okwali, Michael J. Buege, Venkatraman Seshan, Connie L. Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (26): 2327–2331.
https://doi.org/10.1182/blood.2023021274
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy of Subcutaneous Epcoritamab Vs Tisa-Cel in R/R LBCL CAR T-Naive and CAR T-Eligible Patients: An Indirect Comparison

Gilles Salles, Christopher P. Fox, Anthony Wang, Kavita Sail, Abualbishr Alshreef, Michael Moran, Alex Mutebi, Julie Blaedel, Viktor Chirikov, Wei-Jhih Wang, Catherine Thieblemont
Journal: Blood
Blood (2023) 142 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2023-180047
Published: 2023
Journal Articles

Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients

Gabriel Antherieu, Edith Julia, Alizee Maarek, Violaine Safar, Emmanuelle Ferrant, Alexandra Traverse-Glehen, Anne Lazareth, Helene Lequeu, Stéphanie Cordeil, Guillaume Aussedat, Camille Golfier, Dana Ghergus, Pierre Sesques, Lionel Karlin, Fadhela Bouafia Sauvy, Gilles Salles, Emmanuel Bachy, Emmanuel Jouanneau, Francois Ducray, Loic Boussel, Herve Ghesquieres
Journal: Blood
Blood (2023) 142 (Supplement 1): 1764.
https://doi.org/10.1182/blood-2023-179765
Published: 2023
Journal Articles

From Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T- Cell Therapy: Less Is Better

Giovanna Melica, Alejandro Luna De Abia, Magdalena Corona, Joshua Fein, Parastoo B Dahi, Sergio A. Giralt, Ivan Landego, Richard J. Lin, Maria Lia Palomba, Allison Parascondola, Jae H. Park, Gilles Salles, Amethyst Saldia, Michael Scordo, Ana Alarcon Tomas, Gunjan L. Shah, Roni Shouval, Ying Taur, Miguel-Angel Perales, Susan K. Seo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3514.
https://doi.org/10.1182/blood-2023-181997
Published: 2023
Journal Articles

Infectious Complications in Patients with Relapsed or Refractory (R/R) Non-Hodgkin's Lymphoma (NHL) Treated with the Anti-CD20xCD3 Bispecific Antibody (BsAb) Mosunetuzumab

Zainab Shahid, Michelle Okwali, Ashlee Joseph, Susan K. Seo, Jennifer Kimberly Lue, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4403.
https://doi.org/10.1182/blood-2023-187911
Published: 2023
Journal Articles

Impact of Response to Systemic Bridging Therapy on Clinical Outcomes and Cytokine Profiles in Patients Receiving CD19- CAR T-Cell Therapy for B-Cell Lymphoma

Beatriz Wills, Roni Shouval, Jessica R. Flynn, Sean M. Devlin, Allison Parascondola, Amethyst Saldia, Brandon S. Imber, Ana Alarcon Tomas, Ivan Landego, Richard J. Lin, Michael Scordo, Parastoo Bahrami Dahi, Gunjan L. Shah, Andrew Ip, Lori A Leslie, Hyung Chan Suh, Gilles Salles, Miguel-Angel Perales, Maria Lia Palomba
Journal: Blood
Blood (2023) 142 (Supplement 1): 3014.
https://doi.org/10.1182/blood-2023-181116
Published: 2023
Journal Articles

Predicted Functional Consequences of TP53 Alterations and Prognosis in TP53 -Mutated Mantle Cell Lymphoma

Manik Uppal, Erel Joffe, Kurt S. Bantilan, Gilles Salles, Jacob Soumerai, Andrew D. Zelenetz, Anita Kumar
Journal: Blood
Blood (2023) 142 (Supplement 1): 3006.
https://doi.org/10.1182/blood-2023-187599
Published: 2023
Journal Articles

A Phase 2 Study of Minimal Residual Disease (MRD)-Adapted Front Line Venetoclax and Obinutuzumab in Fit Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Obinutuzumab on Tumor Lysis Syndrome (TLS) Risk and Safety of Outpatient Venetoclax Dose Escalation

Lindsey E. Roeker, Andrew D. Zelenetz, Jae H. Park, Andriy Derkach, Mark Blaine Geyer, Prioty Islam, Lorenzo Falchi, Maria Lia Palomba, Anita Kumar, Gilles Salles, Jennifer Kimberly Lue, Aaron D. Goldberg, Bita Fakhri, Catherine C. Coombs, Victoria Falco, Gail Panton, Dianna Tyznar, Dhara Soni, Lauren Nogan, Sonia Lebowitz, Katherine Blesie, Monica Shah, Sarah Court, Christopher E. Jensen, Anthony R. Mato, Meghan C. Thompson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4657.
https://doi.org/10.1182/blood-2023-181661
Published: 2023
Journal Articles

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Gustav Cederquist, Javin Schefflein, Sean M. Devlin, Harper Hubbeling, Kathryn Tringale, Gunjan L. Shah, Ana Alarcon Tomas, Roni Shouval, Carla Hajj, Beatrice Fregonese, Parastoo B. Dahi, Richard J. Lin, Maria Lia Palomba, Miguel-Angel Perales, Gilles Salles, Lorenzo Falchi, Christian Grommes, Michael Scordo, Joachim Yahalom, Brandon S. Imber
Journal: Blood
Blood (2023) 142 (Supplement 1): 4491.
https://doi.org/10.1182/blood-2023-190326
Published: 2023
Journal Articles

Responses and Outcomes after Second-Line Therapy in Transplant-Eligible Patients with DLBCL Relapse over 1 Year after First-Line Therapy

David A Qualls, Gunjan L. Shah, Roni Shouval, Philip Caron, Kevin A. David, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Oscar Boutros Lahoud, Jennifer Kimberly Lue, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Michelle Okwali, Parastoo Bahrami Dahi, Michael Scordo, Richard J. Lin, Miguel-Angel Perales, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 4970.
https://doi.org/10.1182/blood-2023-182733
Published: 2023
Journal Articles

Comparison of Bendamustine Versus Fludarabine/ Cyclophosphamide Lymphodepletion in Adult Patients Receiving CD19 CAR-T Cell Therapy

Ivan Landego, David Nemirovsky, Sean M. Devlin, Beatriz Wills, Allison Parascondola, Amethyst Saldia, Parastoo B. Dahi, Ana Alarcon Tomas, Andrew Ip, Hyung C Suh, Lori A. Leslie, Karthik Nath, Sergio A. Giralt, Richard J. Lin, Maria Lia Palomba, Gilles Salles, Gunjan L. Shah, Roni Shouval, Miguel-Angel Perales, Michael Scordo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3510.
https://doi.org/10.1182/blood-2023-189349
Published: 2023
Journal Articles

Dynamics of Radiomic Features Following Bridging Therapy Determine CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome

Harper Hubbeling, Doris Leithner, Emily A. Silverman, Jessica R. Flynn, Sean M. Devlin, Gunjan L. Shah, Beatrice Fregonese, Akshay Bedmutha, Beatriz Wills, Ana Alarcon Tomas, Allison Parascondola, Amethyst Saldia, Ivan Landego, Parastoo B. Dahi, Sergio A. Giralt, Richard J. Lin, Michael Scordo, Gilles Salles, Joachim Yahalom, Maria Lia Palomba, Heiko Schoder, Miguel-Angel Perales, Roni Shouval, Brandon S. Imber
Journal: Blood
Blood (2023) 142 (Supplement 1): 2123.
https://doi.org/10.1182/blood-2023-187763
Published: 2023
Journal Articles

Potent CD8+ T-Cell Proliferation and Effector Differentiation Following Subcutaneous (SC) Mosunetuzumab Administration in Patients with Untreated, High Tumor-Burden Follicular Lymphoma (FL)

Lorenzo Falchi, Ya-Hui Lin, Lauren Melendez, Paola Ghione, Colette Owens, Paul A. Hamlin, Jennifer Kimberly Lue, Zachary D. Epstein-Peterson, Anita Kumar, Maria Lia Palomba, Pallawi Torka, Michelle Okwali, Alexandra Ferreira Lopes, Anastasia Martinova, Lauren Wood, Clare Grieve, Walter Ramos Amador, Andrew D. Zelenetz, Gilles Salles, Santosha A Vardhana
Journal: Blood
Blood (2023) 142 (Supplement 1): 6116.
https://doi.org/10.1182/blood-2023-189638
Published: 2023
Journal Articles

Predicting Toxicities in Older Adults with Non-Hodgkin Lymphoma (NHL) Receiving Systemic Chemotherapy: A Prospective Geriatric Assessment (GA) Study

Pallawi Torka, Esther Drill, Nivetha Ganesan, Mayan Oliveros, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Paul A. Hamlin
Journal: Blood
Blood (2023) 142 (Supplement 1): 70.
https://doi.org/10.1182/blood-2023-188143
Published: 2023
Journal Articles

Plasma Circulating Tumor DNA (ctDNA) as an Alternative to Tissue DNA for Genotyping of DLBCL: Results from the POLARIX Study

Fabrice Jardin, Vibha Raghavan, Samuel Tracy, Sandhya Balasubramanian, Laurie H. Sehn, Christopher R. Flowers, Franck Morschhauser, Alex F. Herrera, Marek Trněný, Jeff P. Sharman, Gilles Salles, Hervé Tilly, Jonathan W. Friedberg, Will Harris, Jamie H. Hirata, Calvin Lee, Yanwen Jiang, Georg Lenz
Journal: Blood
Blood (2023) 142 (Supplement 1): 169.
https://doi.org/10.1182/blood-2023-178564
Published: 2023
Journal Articles

Treatment Outcomes of Limited Stage Grade 3A Follicular Lymphoma

Reith R Sarkar, Jasme Lee, Zhigang Zhang, Andrew D. Zelenetz, Gilles Salles, Joachim Yahalom, Brandon S. Imber
Journal: Blood
Blood (2023) 142 (Supplement 1): 1681.
https://doi.org/10.1182/blood-2023-191002
Published: 2023
Journal Articles

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Gustav Cederquist, Kathryn Tringale, Carla Hajj, Harper Hubbeling, Jennifer Ma, Alexandra Dreyfuss, Beatrice Fregonese, Gilles Salles, Christian Grommes, Michael Scordo, Lorenzo Falchi, Joachim Yahalom, Brandon S. Imber
Journal: Blood
Blood (2023) 142 (Supplement 1): 1759.
https://doi.org/10.1182/blood-2023-190236
Published: 2023
Journal Articles

Tazemetostat in Combination with Lenalidomide and Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma: Updated Phase 1b Results of Symphony-1 with 22.5 Months Follow-up

Gilles Salles, Steven I. Park, Tycel J. Phillips, Jennifer E. Amengual, David J Andorsky, Philip Campbell, Pamela McKay, John P. Leonard, Yingxue Chen, Jade Chen, Rajat Bannerji, Apoorva Kapopara, Attila Szanto, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 3035.
https://doi.org/10.1182/blood-2023-179910
Published: 2023
Journal Articles

Brentuximab Vedotin-Based Regimens for Older Patients with Newly Diagnosed Classical Hodgkin Lymphoma -Real World Experience

Efrat Luttwak, Nivetha Ganesan, Alexander P. Boardman, Philip Caron, Kevin A. David, Alfredo Rivas-Delgado, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Jennifer Kimberly Lue, Ariela Noy, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3059.
https://doi.org/10.1182/blood-2023-189617
Published: 2023